Oppenheimer Maintains an 'Outperform' on Humana (HUM); Reducing Numbers After Q2 Report

July 31, 2012 9:59 AM EDT Send to a Friend
Get Alerts HUM Hot Sheet
Price: $133.11 +0.36%

Rating Summary:
    7 Buy, 11 Hold, 3 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade HUM Now!
Join SI Premium – FREE
Oppenheimer maintains an 'Outperform' on Humana (NYSE: HUM) price target of $83.00 (from $98.00).

Analyst, Bret Jones, said, "While 2Q12 results were ahead of the company's expectations, it reduced its 2H12 outlook due to lower margins on the rapidly growing new member population ($170M) and higher cost trend across its entire book ($100M). It believes that all but a portion of the higher costs were captured in its FY2013 bids, which were submitted in June. Due to the lower guidance and increased uncertainty, we are lowering our FY2012 (ex-$0.18/share in legal costs) and FY2013 EPS estimates to $7.11 and $7.52 from $7.80 and $8.42."

For an analyst ratings summary and ratings history on Humana click here. For more ratings news on Humana click here.

Shares of Humana closed at $70.55 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT Change

Add Your Comment